This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Carter's Q2 Earnings Miss Estimates, Stock Dips After Tariff Concerns
by Zacks Equity Research
CRI's shares tumble after Q2 earnings miss as tariff concerns weigh on outlook despite stronger sales trends.
Carter's (CRI) Misses Q2 Earnings Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of -60.47% and +0.92%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
What Should Investors Expect From Carter's Ahead of Q2 Earnings?
by Zacks Equity Research
CRI's Q2 revenues are expected to have climbed on baby and global gains, but pricing and costs are likely to have weighed on the bottom line.
Nike (NKE) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Nike (NKE) delivered earnings and revenue surprises of +16.67% and +3.56%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
NIKE Stock Slides Below 50-Day SMA: Buy Opportunity or Risky Affair?
by Rajani Lohia
NKE dips below 50-day SMA as weak margins, tariff risks and slowing growth fuel uncertainty around its premium valuation and near-term direction.
Carter's Q1 Earnings Beat Estimates, Stock Down on Paused Guidance
by Zacks Equity Research
CRI's Q1 results show a mixed performance, beating estimates but declining year over year amid macro pressures, leadership transition and tariff uncertainties.
Carter's (CRI) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 24.53% and 1.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Carter's Q1 Earnings on Deck: Will Adverse Trends Hurt Performance?
by Zacks Equity Research
CRI's first-quarter results are likely to reflect the ongoing effects of a tough macroeconomic backdrop, rising inflation and increased promotional activity.
Strength Seen in Adidas (ADDYY): Can Its 13.2% Jump Turn into More Strength?
by Zacks Equity Research
Adidas (ADDYY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Carter's Shares Plunge 31.4% YTD: What's Next for Investors?
by Zacks Equity Research
CRI witnesses inflation and other macroeconomic headwinds. Higher costs also remain deterrents.
Why Is Carter's (CRI) Down 1.4% Since Last Earnings Report?
by Zacks Equity Research
Carter's (CRI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Carter's Stock Dips 6.6% Post Q4 Earnings: Time to Buy or Stay Put?
by Zacks Equity Research
CRI faces near-term pressures from U.S. Retail weakness, rising costs and macro pressures, which overshadow its Wholesale business growth.
Carter Q4 Earnings & Sales Surpass Estimates, Stock Down
by Zacks Equity Research
CRI's Q4 results show marginal sales growth, but profit falls due to higher freight costs, intense promotional competition and macroeconomic challenges.
Carter's (CRI) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 38.95% and 3.77%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter's Q4 Earnings on the Horizon: Key Factors to Note
by Zacks Equity Research
CRI's fourth-quarter 2024 results are likely to reflect a tough retail landscape, inflationary impacts and increased expenses.
Carter's Stock Plunges to 52-Week Low: Time to Buy or Stay Cautious?
by Zacks Equity Research
CRI navigates a tough market with declining sales and macro pressures. However, strategic pricing and omnichannel efforts offer a path forward.
Carter's Stock Trades at a P/E Discount: Should You Buy, Hold or Sell?
by Zacks Equity Research
CRI's pricing strategy, efficient inventory management and enhanced product offerings have been driving growth amid ongoing macroeconomic challenges.
Zacks Industry Outlook Adidas, Skechers, Steven Madden, Carter's and Wolverine World Wide
by Zacks Equity Research
Adidas, Skechers, Steven Madden, Carter's and Wolverine World Wide have been highlighted in this Industry Outlook article.
Shoes & Retail Apparel Industry Reflects Momentum: 5 Stocks to Benefit
by Rajani Lohia
The Shoes & Retail Apparel industry is driven by innovation, demand and digital investments, benefiting companies like ADDYY, SKX, SHOO, CRI and WWW. Rising costs and reinvestments are challenges.
Carter's Reaps Benefits From Strategic Pricing and Marketing
by Zacks Equity Research
CRI's pricing strategy, efficient inventory management and enhanced product offerings have been driving growth amid ongoing inflationary impacts.
Is the Options Market Predicting a Spike in Carter's (CRI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Carter's (CRI) stock based on the movements in the options market lately.
Carter's Plunges 22% in a Month: What's Next for Investors?
by Zacks Equity Research
CRI battles various uncertainties, such as a tough macroeconomic environment, inflation, generational high interest rates and a slowdown in consumer spending.
Carter's Q3 Earnings Beat Estimates, Sales Decline 4.2% Y/Y
by Zacks Equity Research
CRI experiences soft sales results in the third quarter of 2024, largely driven by weak sales in segments, impacts of inflation and currency headwinds.
Carter's (CRI) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 27.13% and 1.41%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter's to Report Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
Challenging macroeconomic conditions, wavering consumer confidence, rising inflation and increased promotional activity are likely to hurt CRI's Q3 results.